132 related articles for article (PubMed ID: 28319803)
1. Social economic costs of type 1 diabetes mellitus in pediatric patients in Spain: CHRYSTAL observational study.
López-Bastida J; López-Siguero JP; Oliva-Moreno J; Perez-Nieves M; Villoro R; Dilla T; Merino M; Jiang D; Aranda-Reneo I; Reviriego J; Vázquez LA
Diabetes Res Clin Pract; 2017 May; 127():59-69. PubMed ID: 28319803
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of patients admitted to stroke units in Spain.
Alvarez-Sabín J; Quintana M; Masjuan J; Oliva-Moreno J; Mar J; Gonzalez-Rojas N; Becerra V; Torres C; Yebenes M;
Eur J Health Econ; 2017 May; 18(4):449-458. PubMed ID: 27084749
[TBL] [Abstract][Full Text] [Related]
3. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
[TBL] [Abstract][Full Text] [Related]
4. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
[TBL] [Abstract][Full Text] [Related]
5. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
6. Study of direct costs of type 1 diabetes mellitus in Andalusian patients aged 2-16 years.
Álvarez Casaño M; Alonso Montejo MDM; Leiva Gea I; Jiménez Hinojosa JM; Santos Mata MÁ; Macías F; Romero Pérez MDM; de Toro M; Martínez G; Munguira P; Vivas G; López Siguero JP
Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):480-486. PubMed ID: 31122889
[TBL] [Abstract][Full Text] [Related]
7. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
[TBL] [Abstract][Full Text] [Related]
8. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
9. High direct costs of medical care in patients with Type 1 diabetes attending a referral clinic in a government-funded hospital in Northern India.
Katam KK; Bhatia V; Dabadghao P; Bhatia E
Natl Med J India; 2016; 29(2):64-7. PubMed ID: 27586208
[TBL] [Abstract][Full Text] [Related]
10. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
Kuhlmann A; Schmidt T; Treskova M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():79-87. PubMed ID: 27086322
[TBL] [Abstract][Full Text] [Related]
11. Social/economic costs and quality of life in patients with haemophilia in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
[TBL] [Abstract][Full Text] [Related]
12. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
[TBL] [Abstract][Full Text] [Related]
13. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
[TBL] [Abstract][Full Text] [Related]
14. Healthcare reimbursement costs of children with type 1 diabetes in the Netherlands, a observational nationwide study (Young Dudes-4).
Spaans EAJM; van Dijk PR; Groenier KH; Brand PLP; Kleefstra N; Bilo HJG
BMC Endocr Disord; 2018 Aug; 18(1):57. PubMed ID: 30119628
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
[TBL] [Abstract][Full Text] [Related]
16. Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain.
Lopez-Bastida J; Oliva Moreno J; Worbes Cerezo M; Perestelo Perez L; Serrano-Aguilar P; Montón-Álvarez F
BMC Health Serv Res; 2012 Sep; 12():315. PubMed ID: 22970797
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
[TBL] [Abstract][Full Text] [Related]
18. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
[TBL] [Abstract][Full Text] [Related]
19. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
[TBL] [Abstract][Full Text] [Related]
20. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.
Mata-Cases M; Casajuana M; Franch-Nadal J; Casellas A; Castell C; Vinagre I; Mauricio D; Bolíbar B
Eur J Health Econ; 2016 Nov; 17(8):1001-1010. PubMed ID: 26542160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
